New & Noteworthy
PMDA Approves Jarvik 2000 Heart in Japan
The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has granted approval to the Shonin (or pre-market approval) application submitted by Century Medical, Inc., (CMI) for the Jarvik 2000 Heart. [Read More]
Full FDA Approval of the Jarvik 2000® Destination Therapy Trial
Device to Provide Long-term, Permanent Support for Heart Failure Patients Who are Not Eligible for Transplant. Approval was also granted for Continuing Access Protocol (CAP) Patients Following Completion of Enrollment in the Bridge to Transplant Trial. [Read More]
Learn more about the behind-the-ear cable design of the Jarvik 2000 model to be used in the DT study. The study is designed to determine if this design is superior to LVADs that use an abdominal cable and have an abdominal pump pocket.